Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

US Patent 12433908 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating motor neuron diseases2025
Quinoxalinone compounds, compositions, methods, and kits for increasing genome e2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors2025
Nicotinamide riboside for use in treating or preventing liver damage2024
Nicotinamide riboside for use in treating or preventing liver damage2024
Crystalline forms of nicotinamide riboside chloride2024
Crystalline forms of nicotinamide riboside chloride2024
DNA-PK inhibitors2024
DNA-PK inhibitors2023
Treating and preventing motor neuron diseases using nicotinamide riboside2023
Methods of synthesizing nicotinamide riboside2023
Methods of synthesizing nicotinamide riboside2023